Company News: Express Scripts, Medco, Roche, Eli Lilly

Share this article:
Pharmacy benefit manager (PBM) Express Scripts said it plans to buy rival Medco Health Solutions, currently the largest PBM, for $29.1 billion. A combined company could have more pull in negotiating drug prices. The planned merger comes shortly after Medco lost its biggest contract, an $11 billion account with UnitedHealth Group which had accounted for 17% of Medco's business.

Roche said sales were down 4% and 2% for the second quarter and first six months, respectively. Accounting for some of this decline were decreases in sales of cancer drug Avastin (down 7%) and leukemia med Rituxan (down 3%). Diagnostics sales were also down about 2%.

Eli Lilly reported second-quarter revenue up 9% to $6.3 billion, beating analyst consensus by 4%. Lilly did not include any significant pipeline updates in the Q2 report.


Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Ranbaxy extends branded Diovan's life

Ranbaxy may be on the blocks, but it has a hold on the right to produce generics of the Novartis heart medication Diovan. Only problem: it can't, and that is good news for Novartis.

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.